Table 3.
Variable | Poor Adherence* | Good Adherence** | Adjusted OR (95% CI) | p |
---|---|---|---|---|
Illness perceptions (B-IPQ), mean (SD) | ||||
Consequence | 3.45 (2.44) | 2.99 (2.46) | 0.90 (0.79,1.04) | 0.142 |
Timeline | 5.95 (3.43) | 8.50 (2.49) | 1.22 (1.10,1.35) | <0.001 |
Control | 6.28 (2.54) | 7.48 (2.35) | 1.04 (0.92,1.17) | 0.581 |
Identity | 3.58 (2.17) | 3.13 (2.33) | 0.98 (0.84,1.14) | 0.802 |
Medication beliefs (BMQ), mean (SD) | ||||
Medication-Necessity | 3.19 (0.80) | 3.77 (0.71) | 2.67 (1.76,4.06) | <0.001 |
Medication-Concerns | 2.84 (0.73) | 2.44 (0.69) | 0.39 (0.26,0.60) | <0.001 |
Inhaler medication, n (%) | ||||
Combined ICS-LABA | 97 (51.1) | 93 (48.9) | 2.50 (1.41,4.44) | 0.02 |
ICS monotherapy | 94 (70.7) | 39 (29.3) | 1 | - |
Notes: *Poor adherence refers to patients with mean MARS score <4.5. **Good adherence refers to patients with mean MARS score ≥4.5.